Research map: Targeting pathophysiological hallmark genes and pathways in diabesotension to advance personalized therapeutic interventions
Back to the article
Papers in this map
- g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) · Uku Raudvere · 2019 · 5565 citations · Cited by this paper
- CADASIL type 1 with cysteine-sparing P572L mutation on exon 11 presenting as focal onset epilepsy: a case report · 2026 · Related
- NF-κB, Inflammation, and Metabolic Disease · Rebecca G. Baker · 2011 · 1961 citations · Cited by this paper
- Assessment of plasminogen activator inhibitor-1 4G/5G genetic polymorphism among Egyptian patients with Budd-Chiari syndrome · 2026 · Related
- The PI3K/AKT pathway in obesity and type 2 diabetes · Xingjun Huang · 2018 · 1704 citations · Cited by this paper
- In silico identification of damaging CDK4 variants linked to cancer pathogenesis: functional and structural insights · 2026 · Related
- Glucagon-like peptide-1 receptor: mechanisms and advances in therapy · Zhikai Zheng · 2024 · 982 citations · Cited by this paper
- Investigation of osteoprotegerin gene polymorphisms and serum level as a predictive marker of cardiac abnormalities in beta thalassemia major · 2026 · Related
- Gene: a gene-centered information resource at NCBI · Garth Brown · 2014 · 742 citations · Cited by this paper
- CRISPR-Cas9 technology: a breakthrough in cancer gene therapy · 2026 · Related
- Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications · Yohannes Tsegyie Wondmkun · 2020 · 710 citations · Cited by this paper
- Systems-level characterization of the molecular landscape of odontogenic keratocyst: insights from differential gene expression and pathway analysis · 2026 · Related
- Obesity, hypertension, and chronic kidney disease · John Edward Hall · 2014 · 521 citations · Cited by this paper
- A decade of GWAS in Parkinson’s disease: ancestry-specific insights and methodological advances (2015–2025) · 2026 · Related
- An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice · Shannon M. Reilly · 2013 · 447 citations · Cited by this paper
- Construction of a ceRNA network specific for cumulus cells in polycystic ovary syndrome · 2026 · Related
- Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans · Julia Szendroedi · 2014 · 419 citations · Cited by this paper
- Remarkable response to growth hormone therapy in a patient with peters plus syndrome with posterior segment ocular involvement: long-term follow-up expanding clinical experience · 2026 · Related
- Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β -Cell Dysfunction · Kevin Noel Keane · 2015 · 383 citations · Cited by this paper
- Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB · Leen Catrysse · 2017 · 345 citations · Cited by this paper
- Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions · Sourbh Suren Garg · 2023 · 223 citations · Cited by this paper
- Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications · Graziela Z Kalil · 2011 · 222 citations · Cited by this paper
- Obesity and Kidney Disease · Csaba Pal Kovesdy · 2017 · 200 citations · Cited by this paper
- Insulin resistance and hypertension: new insights · Manoocher Soleimani · 2015 · 187 citations · Cited by this paper
- Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management · Fadi A El-Atat · 2004 · 122 citations · Cited by this paper
- The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells · Amaara Marzook · 2021 · 121 citations · Cited by this paper
- Role of PI3K/AKT Pathway in Insulin-Mediated Glucose Uptake · Ewa Świderska · 2019 · 115 citations · Cited by this paper
- The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets · Rana Taheri · 2024 · 108 citations · Cited by this paper
- Inflammation and the metabolic syndrome: Role of angiotensin II and oxidative stress · León Ferder · 2006 · 101 citations · Cited by this paper
- Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity · Daniel T. Meier · 2024 · 97 citations · Cited by this paper
- Diabetes and Hypertension: Epidemiology of the Relationship and Pathophysiology of Factors Associated With These Comorbid Conditions · Mark H. Schutta · 2007 · 89 citations · Cited by this paper
- Inflammation, Oxidative Stress, Insulin Resistance, and Hypertension as Mediators for Adverse Effects of Obesity on the Brain: a Review · Mahnaz Ghowsi · 2021 · 71 citations · Cited by this paper
- Oxidative Stress and Inflammation in Obesity, Diabetes, Hypertension, and Related Cardiometabolic Complications · Joseph Fomusi Ndisang · 2014 · 61 citations · Cited by this paper
- Visceral adiposopathy: a vascular perspective · Melissa G. Farb · 2015 · 61 citations · Cited by this paper
- Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program · Ildiko Lingvay · 2023 · 57 citations · Cited by this paper
- Endothelial dysfunction: mechanisms and contribution to diseases · Amir Ajoolabady · 2024 · 54 citations · Cited by this paper
- Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus · Ioannis G. Lempesis · 2023 · 52 citations · Cited by this paper
- Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms–a comprehensive review · Zhen Xu · 2025 · 39 citations · Cited by this paper
- Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia · Marcus DaSilva Goncalves · 2022 · 33 citations · Cited by this paper
Source: OpenAlex (CC0)